|
Aurobindo Pharma Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
91749.23 Cr.
|
P/BV
|
2.42
|
Book Value (Rs.)
|
652.39
|
|
52 Week High/Low (Rs.)
|
1637/1016
|
FV/ML
|
1/1
|
P/E(X)
|
26.18
|
|
Bookclosure
|
17/04/2026
|
EPS (Rs.)
|
60.34
|
Div Yield (%)
|
0.25
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 8751.50 | 8604.51 | 8236.96 | 7791.77 | 8381.12 |
| Other Operating Income | 101.84 | 41.39 | 48.74 | 76.37 | 1.00 |
| Total Income From Operations | 8853.34 | 8645.90 | 8285.70 | 7868.14 | 8382.12 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2505.35 | 2754.88 | 2509.80 | 2535.16 | 2799.51 |
| Purchase of Traded Goods | 931.48 | 892.65 | 846.05 | 807.80 | 636.18 |
| Increase/Decrease in Stocks | -7.76 | -166.32 | -16.99 | -103.74 | -7.81 |
| Employees Cost | 1373.98 | 1310.06 | 1277.33 | 1228.80 | 1162.64 |
| Depreciation | 478.57 | 464.73 | 429.19 | 405.70 | 444.43 |
| Other Expenses | 2297.51 | 2081.29 | 1991.41 | 1797.09 | 1999.68 |
| Total Expenses | 7579.13 | 7337.29 | 7036.79 | 6670.81 | 7034.63 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1274.21 | 1308.61 | 1248.91 | 1197.33 | 1347.49 |
| Other Income | 117.04 | 187.64 | 120.59 | 105.30 | 134.81 |
| P/L Before Interest, Excpt. Items & Tax | 1391.25 | 1496.25 | 1369.50 | 1302.63 | 1482.30 |
| Interest | 98.21 | 92.77 | 95.24 | 97.75 | 115.02 |
| P/L Before Exceptional Items & Tax | 1293.04 | 1403.48 | 1274.26 | 1204.88 | 1367.28 |
| Exceptional Items | 0.00 | -65.33 | 0.00 | 0.00 | 0.00 |
| P/L Before Tax | 1293.04 | 1338.15 | 1274.26 | 1204.88 | 1367.28 |
| Tax | 369.77 | 428.72 | 427.79 | 382.60 | 432.26 |
| P/L After Tax from Ordinary Activities | 923.27 | 909.43 | 846.47 | 822.28 | 935.02 |
| Net Profit/Loss For the Period | 923.27 | 909.43 | 846.47 | 822.28 | 935.02 |
| Minority Interest | 0.42 | 0.48 | 0.32 | 0.55 | 0.64 |
| Share Of P/L Of Associates | -2.43 | 0.37 | 1.66 | 1.92 | -32.19 |
| Net P/L After Minority Interest & Share Of Associates | 921.26 | 1138.01 | 848.45 | 824.75 | 903.47 |
| | | | | | |
| Equity Share Capital | 58.08 | 58.08 | 58.08 | 58.08 | 58.08 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 15.86 | 15.67 | 14.61 | 14.20 | 15.56 |
| Diluted EPS (Rs.) | 15.86 | 15.67 | 14.61 | 14.20 | 15.56 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 15.86 | 15.67 | 14.61 | 14.20 | 15.56 |
| Diluted EPS (Rs.) | 15.86 | 15.67 | 14.61 | 14.20 | 15.56 |
| | | | | | |
| PBITOE Margin (%) | 14.39 | 15.13 | 15.07 | 15.21 | 16.07 |
| PBTE Margin (%) | 14.60 | 16.23 | 15.37 | 15.31 | 16.31 |
| PBT Margin (%) | 14.60 | 15.47 | 15.37 | 15.31 | 16.31 |
| PAT Margin (%) | 10.42 | 10.51 | 10.21 | 10.45 | 11.15 |
| PAT After MI And SOA Margin (%) | 10.40 | 13.16 | 10.23 | 10.48 | 10.77 |
